Anti-TLR4 antibody,Abcam,AB13556

Product Specifications Anti-TLR4 antibody (ab13556) is a rabbit polyclonal antibody and is validated for use in Flow Cyt, WB in human samples. Quality and Validation Anti-TLR4 antibody (ab13556) specifically detects TLR4 (UniProt ID: O00206; Molecular weight: 93kDa) and is sold in 100 µg selling sizes. Abcam's high quality validation processes ensure Anti-TLR4 antibody (ab13556) has high sensitivity and specificity. Anti-TLR4 antibody (ab13556) has been cited over 335 times in peer reviewed journals and is trusted by the scientific community. Anti-TLR4 antibody (ab13556) has 19 independent reviews from customers.

Host

Rabbit

Reactivity

Human

Application

Flow Cyt, WB

Platform ID

BAB932775255

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-TLR4 antibody
Cat. No.AB13556
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationFlow Cyt, WB
ClonalityPolyclonal
Concentration1 mg/mL Batch dependent concentration
ImmunogenSynthetic Peptide within Human TLR4 aa 400-450. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein G
Appearance/FormLiquid
ShippingBlue Ice
FormulationPreservative: 0.09% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Transmembrane receptor that functions as a pattern recognition receptor recognizing pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) to induce innate immune responses via downstream signaling pathways (PubMed : 10835634, PubMed : 15809303, PubMed : 16622205, PubMed : 17292937, PubMed : 17478729, PubMed : 20037584, PubMed : 20711192, PubMed : 23880187, PubMed : 27022195, PubMed : 29038465). At the plasma membrane, cooperates with LY96 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed : 27022195). Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+) (PubMed : 20711192). Mechanistically, acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed : 10835634, PubMed : 21393102, PubMed : 27022195, PubMed : 36945827, PubMed : 9237759). Alternatively, CD14-mediated TLR4 internalization via endocytosis is associated with the initiation of a MYD88-independent signaling via the TICAM1-TBK1-IRF3 axis leading to type I interferon production (PubMed : 14517278). In addition to the secretion of proinflammatory cytokines, initiates the activation of NLRP3 inflammasome and formation of a positive feedback loop between autophagy and NF-kappa-B signaling cascade (PubMed : 32894580). In complex with TLR6, promotes inflammation in monocytes/macrophages by associating with TLR6 and the receptor CD86 (PubMed : 23880187). Upon ligand binding, such as oxLDL or amyloid-beta 42, the TLR4 : TLR6 complex is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway (PubMed : 23880187). In myeloid dendritic cells, vesicular stomatitis virus glycoprotein G but not LPS promotes the activation of IRF7, leading to type I IFN production in a CD14-dependent manner (PubMed : 15265881, PubMed : 23880187). Required for the migration-promoting effects of ZG16B/PAUF on pancreatic cancer cells. See full target information TLR4

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.